OmniAb (OABI) Current Taxes (2022 - 2023)

OmniAb's (OABI) quarterly Current Taxes came in at $3.5 million in Q3 2023, little changed on a QoQ basis from $3.5 million in Q2 2023.

OmniAb (OABI) Current Taxes (2022 - 2023) Analysis & Trends

OmniAb (OABI) has 2 years of Current Taxes data on file, last reported at $3.5 million in Q3 2023.

On a quarterly basis, Current Taxes changed N/A year-over-year to $3.5 million in Q3 2023; TTM through Sep 2023 was $3.5 million, a N/A change from a year earlier, with the FY2022 full-year figure at $3.5 million, changed N/A from the prior year.
Current Taxes for Q3 2023 stood at $3.5 million, roughly flat from $3.5 million in the prior quarter.
Over the last five years, Current Taxes for OABI reached as high as $3.5 million in Q1 2023 and fell as low as $3.5 million in Q2 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	63.52 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	49.00 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	OmniAb	261.62 Mn	212.55 Mn	14.41 Mn	-

Download Data